Increases in Organ Donation in Donor Hospitals Changing Organ Procurement Organization Affiliations

A retrospective cohort study of two donor hospitals that switched Organ Procurement Organization (OPO) affiliations found that the change led to statistically significant increases in organ donors and transplants driven by improved donor conversion, suggesting that realigning hospital-OPO relationships can enhance donation activity without negatively impacting the system.

The Gist

The Great Organ Donation Switch: A Story of Better Teams and More Lives Saved

Imagine the United States' organ donation system as a massive, complex sports league. In this league, Organ Procurement Organizations (OPOs) are the "coaching staffs" responsible for finding and managing potential organ donors in their specific regions (called Donation Service Areas). Donor Hospitals are the "stadiums" where potential donors are identified.

For years, every stadium was assigned a specific coach. If a stadium felt its coach wasn't doing a great job, they were stuck with them. But recently, the league's rulebook (the government) changed. It said, "If a stadium thinks a different coach could help them win more games (save more lives), they can ask for a waiver to switch teams."

The Big Question:
People were worried. Critics said, "If you break up a long-standing relationship between a stadium and its coach, everything will fall apart! The system will collapse, and fewer people will get organs."

The Experiment:
Two major hospitals (Renown Regional Medical Center in Nevada and North Carolina Baptist Hospital) decided to test this. They asked for and received permission to switch to different, high-performing OPOs. This study looked at what happened to these two hospitals compared to their neighbors who stayed with their original coaches.

What Happened? (The Results)
The results were surprising and very positive. Think of it like this:

• The "Stadium" didn't change: The number of people passing away in the hospitals (the pool of potential donors) stayed exactly the same. The "raw material" didn't increase.
• The "Game Plan" changed: However, after switching coaches, these two hospitals started "winning" much more often.
  • More Donors: They successfully identified and recovered organs from more donors.
  • More Transplants: They got more organs into patients who needed them.

It wasn't that more people died; it was that the new coaching staff was better at turning potential into action.

Why Did It Work? (The Secret Sauce)
Why did the new coaches do better? The study found that the new OPO (LifeShare Carolinas) didn't just send a letter; they rolled up their sleeves and changed the daily routine:

1. They sat at the table: Instead of calling from an office, the new OPO staff set up shop inside the hospital every single day. They were right there with the doctors and nurses.
2. They fixed the communication: They built a direct, instant messaging line (using a secure chat app) so the hospital and the OPO could talk instantly, rather than waiting for emails or phone tags.
3. They listened: They formed special committees to find exactly where the old process was clunky and fixed those specific problems.
4. They invested in families: They put extra money and staff into supporting the families of the donors, ensuring the process was handled with care and efficiency.

The Bottom Line
This study is like a proof-of-concept for a new strategy. It shows that when a hospital switches to a more effective OPO, it doesn't cause chaos. Instead, it acts like a turbocharger.

The fear that "changing coaches will ruin the game" turned out to be unfounded. In fact, the data suggests that letting hospitals choose the best coaching staff for their specific needs can lead to an immediate jump in the number of lives saved.

In Simple Terms:
If you have a team that isn't performing well, sometimes the best way to fix it isn't to work harder at the same old things, but to bring in a new coach with a better playbook and more hands-on support. That's exactly what happened here, and the result was more organs saved and more families finding hope.

Technical Summary

1. Problem Statement and Context

The study addresses a critical policy debate surrounding the 2020 Centers for Medicare and Medicaid Services (CMS) OPO Final Rule. This rule introduced a tiered certification system for Organ Procurement Organizations (OPOs), allowing high-performing OPOs (Tier 1) to compete for donor hospitals in the service areas of lower-performing OPOs (Tier 2 and 3).

A specific mechanism within this framework allows donor hospitals to request a CMS waiver to switch their designated OPO affiliation if it is expected to increase organ donation. While this pathway has existed since before 2006, it was rarely utilized until recently.

• The Conflict: There are significant concerns among policymakers and the transplant community that allowing donor hospitals to switch OPOs could disrupt long-standing relationships, destabilize the donation system, and potentially reduce organ recovery rates in specific geographic areas.
• The Gap: Prior to this study, there was no empirical data evaluating whether granting these waivers actually leads to increased donation activity or causes system collapse.

2. Methodology

The authors conducted a retrospective cohort study utilizing data from the Organ Procurement and Transplantation Network (OPTN).

• Study Period: August 1, 2024, to November 30, 2025 (ensuring equal pre- and post-waiver timeframes).
• Study Design: A Difference-in-Differences (DID) analytic framework was employed to estimate the causal impact of the intervention.
  • Intervention Group: Two specific donor hospitals that switched OPO affiliations in April 2025:
    1. Renown Regional Medical Center (Nevada): Switched from Donor Network West (CADN) to Nevada Donor Network (NVLV).
    2. North Carolina Baptist Hospital: Switched from Honor Bridge (NCNC) to LifeShare Carolinas (NCCM).
  • Control Group: All other donor hospitals within the same Donation Service Areas (DSAs) that maintained their original OPO affiliations.
• Statistical Analysis:
  • Primary Outcomes: Monthly number of donors recovered and monthly number of organs transplanted.
  • Model: Multilevel mixed-effects linear regression models with random intercepts for each hospital to account for baseline differences and within-hospital correlations.
  • Covariates: Calendar month, pre/post-waiver era, and an interaction term (Hospital Type × Era). The interaction term served as the DID estimator.
  • Significance Threshold: A p-value of <0.1 was considered statistically significant for the interaction term.
• Data Scope: The study analyzed aggregate monthly data on reported deaths, donors recovered, and organs transplanted.

3. Key Contributions

• First Empirical Evidence: This is the first study to empirically evaluate the impact of donor hospital OPO realignment on donation metrics.
• Mechanism Analysis: Beyond statistical outcomes, the authors qualitatively investigated how the improvements occurred by communicating with the leadership of the new OPO (LifeShare Carolinas), identifying specific operational changes (e.g., leadership committees, daily onsite staff, electronic referrals via Epic Secure Chat).
• Policy Relevance: The study provides time-sensitive data directly relevant to the upcoming 2026 OPO certification cycle, where high-performing OPOs will bid for donor hospitals currently managed by lower-performing OPOs.

4. Results

The study found that switching OPO affiliations resulted in immediate and statistically significant increases in donation activity, driven by improved conversion rather than changes in referral volume.

• Donors Recovered:
  • Control Hospitals: Mean monthly donors remained stable (56.6 pre-waiver vs. 57.5 post-waiver).
  • Intervention Hospitals: Mean monthly donors increased significantly from 5.6 (pre-waiver) to 7.9 (post-waiver).
• Organs Transplanted:
  • Control Hospitals: Mean monthly organs remained stable (170.9 pre-waiver vs. 169.2 post-waiver).
  • Intervention Hospitals: Mean monthly organs increased substantially from 16.5 (pre-waiver) to 24.9 (post-waiver).
• Reported Deaths: The mean number of reported deaths at both control and intervention hospitals remained stable across pre- and post-waiver periods, indicating that the increase in donors was not due to an increase in potential donor pool size (deaths) but rather improved donor conversion rates.
• Statistical Significance: The DID estimator (interaction term) was statistically significant (p < 0.1) for both donors recovered and organs transplanted, confirming that the changes in the intervention group were distinct from the control group trends.

5. Significance and Conclusion

• Counter to Concerns: The findings directly refute the hypothesis that changing OPO affiliations harms the donation system. Instead, the data suggest that realignments can lead to significant, immediate increases in organ donation and transplantation.
• Driver of Change: The increase was driven by improved donor conversion (turning reported deaths into actual donors) rather than changes in referral patterns or organ yield per donor. The authors attribute this to operational improvements such as dedicated onsite staff, leadership committees, and streamlined electronic communication.
• Policy Implications: The authors conclude that CMS and the transplant community should feel confident that granting waivers and facilitating OPO realignments will not negatively impact donation. These data support the continuation of waiver requests and the competitive bidding process for donor hospitals in the 2026 recertification cycle as a viable strategy to increase the organ supply.
• Limitations: The study is limited by a small sample size (only two intervention hospitals) and a short follow-up period (8 months). Longer-term data is required to assess the durability of these improvements.

Final Takeaway: Donor hospitals that switch to higher-performing OPOs via CMS waivers experience a rapid, statistically significant boost in organ donation activity, suggesting that OPO competition and realignment are effective mechanisms for improving the organ transplant system.